Free Trial

Fortrea (FTRE) Competitors

Fortrea logo
$4.95 +0.26 (+5.46%)
As of 09:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FTRE vs. LFST, ARDT, NHC, TDOC, VRDN, GRAL, AHCO, AGL, PNTG, and AVAH

Should you be buying Fortrea stock or one of its competitors? The main competitors of Fortrea include LifeStance Health Group (LFST), Ardent Health (ARDT), National HealthCare (NHC), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), GRAIL (GRAL), AdaptHealth (AHCO), Agilon Health (AGL), The Pennant Group (PNTG), and Aveanna Healthcare (AVAH). These companies are all part of the "healthcare" industry.

Fortrea vs. Its Competitors

Fortrea (NASDAQ:FTRE) and LifeStance Health Group (NASDAQ:LFST) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, valuation, profitability, dividends and risk.

LifeStance Health Group has lower revenue, but higher earnings than Fortrea. LifeStance Health Group is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortrea$2.69B0.17-$328.50M-$8.79-0.56
LifeStance Health Group$1.25B1.29-$57.44M-$0.10-41.61

LifeStance Health Group has a net margin of -2.78% compared to Fortrea's net margin of -29.43%. Fortrea's return on equity of 2.84% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Fortrea-29.43% 2.84% 1.06%
LifeStance Health Group -2.78%-2.47%-1.69%

Fortrea has a beta of 1.76, suggesting that its share price is 76% more volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500.

In the previous week, Fortrea had 35 more articles in the media than LifeStance Health Group. MarketBeat recorded 40 mentions for Fortrea and 5 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.54 beat Fortrea's score of 0.03 indicating that LifeStance Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fortrea
1 Very Positive mention(s)
1 Positive mention(s)
35 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral
LifeStance Health Group
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Fortrea currently has a consensus target price of $14.00, indicating a potential upside of 183.06%. LifeStance Health Group has a consensus target price of $8.50, indicating a potential upside of 104.28%. Given Fortrea's higher probable upside, research analysts plainly believe Fortrea is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fortrea
2 Sell rating(s)
12 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86
LifeStance Health Group
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.83

85.5% of LifeStance Health Group shares are held by institutional investors. 0.4% of Fortrea shares are held by company insiders. Comparatively, 6.6% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

LifeStance Health Group beats Fortrea on 10 of the 17 factors compared between the two stocks.

Get Fortrea News Delivered to You Automatically

Sign up to receive the latest news and ratings for FTRE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FTRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FTRE vs. The Competition

MetricFortreaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$421.73M$2.92B$5.52B$9.40B
Dividend YieldN/A2.47%4.00%4.03%
P/E Ratio-0.5618.6227.4919.22
Price / Sales0.17308.88441.5699.38
Price / Cash2.9840.8024.9928.17
Price / Book0.337.648.235.70
Net Income-$328.50M-$55.16M$3.24B$257.84M
7 Day Performance4.79%3.59%2.56%2.96%
1 Month Performance-7.03%13.65%8.36%13.26%
1 Year Performance-81.55%3.00%33.96%17.12%

Fortrea Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FTRE
Fortrea
3.7256 of 5 stars
$4.95
+5.5%
$14.00
+183.1%
-82.1%$421.73M$2.69B-0.5615,500Trending News
LFST
LifeStance Health Group
3.0987 of 5 stars
$4.17
-1.2%
$8.50
+103.8%
-24.2%$1.64B$1.25B-41.7010,218
ARDT
Ardent Health
3.5295 of 5 stars
$10.93
-1.6%
$20.30
+85.8%
-36.8%$1.59B$5.97B6.7024,900
NHC
National HealthCare
N/A$97.31
-0.1%
N/A-21.8%$1.50B$1.37B12.1912,400News Coverage
TDOC
Teladoc Health
2.6105 of 5 stars
$8.34
+3.5%
$9.65
+15.8%
-8.3%$1.41B$2.57B-1.415,500News Coverage
Upcoming Earnings
VRDN
Viridian Therapeutics
3.1977 of 5 stars
$16.79
+1.6%
$37.56
+123.7%
+16.0%$1.35B$300K-4.3650
GRAL
GRAIL
0.585 of 5 stars
$34.35
-2.4%
$31.50
-8.3%
+107.2%$1.27B$125.60M-0.561,360
AHCO
AdaptHealth
3.7297 of 5 stars
$9.15
-0.8%
$13.40
+46.4%
-14.0%$1.24B$3.26B16.0510,500Positive News
AGL
Agilon Health
2.7414 of 5 stars
$2.15
+1.2%
$4.71
+119.8%
-68.9%$877.58M$6.06B-3.641,076
PNTG
The Pennant Group
3.3973 of 5 stars
$23.24
-0.8%
$33.80
+45.4%
-14.4%$807.61M$695.24M30.587,000
AVAH
Aveanna Healthcare
2.2437 of 5 stars
$4.03
+1.8%
$5.25
+30.3%
+17.2%$772.57M$2.02B201.5033,500News Coverage
Analyst Upgrade
Gap Up

Related Companies and Tools


This page (NASDAQ:FTRE) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners